Table 1 Characteristics of cardiac surgical patients who were randomised to receive either succinylated gelatin (4%) (GEL) or compound sodium lactate (CSL) as resuscitation fluid after cardiac surgery
Characteristic | GEL (n = 20) | CSL (n = 20) |
|---|---|---|
Age (years) | 67 (59–70) | 68 (58–72) |
Male, n (%) | 14 (70) | 17 (85) |
Body weight (kg) | 82 (72–97) | 81 (70–96) |
NYHA class, n (%) | ||
 1 | 12 (60) | 13 (65) |
 2 | 3 (15) | 5 (25) |
 3 | 5 (25) | 2 (10) |
LVEF (%) | 56 (46–63) | 60 (45–63) |
Preoperative serum creatinine concentration (μmol/L) | 76 (70–93) | 82 (65–98) |
Procedure type, n (%) | ||
 CABG | 11 (55) | 14 (70) |
 Valve replacement | 5 (25) | 4 (20) |
 Other | 4 (20) | 2 (10) |
EuroSCORE II mortality predicted risk (%) | 1.24 (0.79–1.82) | 1.03 (0.82–1.95) |
CPB, n (%) | 15 (75) | 14 (70) |
 Pump time (mins)* | 103 (82–144) | 98 (76–110) |
 Cross clamp time (mins)* | 86 (47–122) | 55 (47–75) |
Time-to-enrol** (mins) | 75 (36–266) | 114 (41–391) |
 Urine output at enrolment (mL/kg/h) | 0.6 (0.3–1.7) | 0.8 (0.3–1.5) |